The goal of the study is to phenotype and genotype patients with rare hypothalamic and pituitary disorders and identify biomarkers of disease diagnosis, presentation, and progression. We are investigating genetic mechanisms of pituitary tumorigenesis as well as genomic/transcriptomic markers of disease presentation and severity. Patients with suspected or confirmed hypothalamic and/or pituitary disorders and their family members are recruited. Biospecimens including peripheral blood, urine, tumor tissue (as available), and/or stool are collected. Genetic analysis may include a variety of techniques including peripheral blood or tumor tissue targeted Sanger sequencing of one or few genes, peripheral blood or tumor tissue whole exome sequencing, and other as applicable.

Phenotyping and Therapeutic Approaches for Patients with    Sellar/Suprasellar Disorders

21 variables across Demographics, Race and Ethnicity

Phenotyping and Therapeutic Approaches for Patients with Sellar/Suprasellar Disorders

Demographics (4)

Race and Ethnicity (1)

Other (16)